   |
|
SYMPOSIUM EDITORIAL |
|
| Year : 2013 | Volume
: 58
| Issue : 2 | Page : 124-126 |
|
| Collaboration culture in medicine |
|
|
Saravu R Narahari
Institute of Applied Dermatology, Kasaragod, Kerala, India
| Date of Web Publication | 5-Mar-2013 |
Correspondence Address:
Saravu R Narahari
Institute of Applied Dermatology, Kasaragod, Kerala
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.108042
|
|
How to cite this article:
Narahari SR. Collaboration culture in medicine. Indian J Dermatol 2013;58:124-6 |
"Integrative Medicine (IM) selects best practice of public health and biomedicine." It is increasingly felt that IM would complement modern medicine by providing cost effective treatment. IM combines latest scientific advances with profound insight of ancient healing systems. Complementary and alternative systems of medicine (CAM) are playing vital role in public health by the virtue of their acceptance by people with or without government backing. However, experts are divided on its utility to meet the global challenge of providing affordable and quality health care. [1],[2],[3] Ryan's article in this issue (Symposium of Integrative Dermatology page no. 132-141) analyses their arguments. He highlights the benefits of IM and CAM to the public health program particularly to manage large number of common diseases affecting rural populations. Quoting his association with the Institute of Applied Dermatology (IAD) Kasaragod, Kerala, he disapproves the undue concern on safety of IM. He improves the Hippocratic phrase as "Do (k) no (w) harm" to remind the enthusiasts on adverse events and toxicities of allopathy and dangers of indiscriminate use of CAM.
Protocols of IM evolved from the clinical observations in patients who simultaneously used biomedicine and CAM. [4] In India, patients practiced it themselves long before doctors realized it has value. This was encouraged by over-the-counter availability of many CAM drugs. Indian media regularly carry columns of reputed ayurveda doctors on CAM utility for various chronic ailments. This is supported by literature on comparable biomedical diagnosis in general health media. Furthermore, the government issues licenses to sell CAM and allopathy from one and the same pharmacy. Ryan writes that collaboration between various approaches in medical practice within and outside of allopathy existed long since. These approaches although governed by different philosophies benefited patients. He illustrates it referring to the works of William Osler and Garrod and his own experiences through his associations with Krebs and Richard doll. Ryan feels it is foolish to make judgments by comparing the approaches of "these knights of medicine."
Ryan appeals to us to make use of any approach to treatment if it is proved of efficacious. He advises not to ignore the advantages of IM such as low-cost technology, accessibility to most people, and safety over the disease itself. Having seen himself the benefits of CAM in Asia and Africa, he became a strong advocate of IM. He practiced what he preached. Ryan's Oxford department of dermatology conducted several studies on wound healing with herbals. He invited Dr. Gerard Bodeker, a strong proponent of CAM in Europe and South East Asia to establish Gifts of Health in Oxford. Later, as Secretary General of International Foundation for Dermatology, he began a new program "Skin care for all." [5] He collaborated with groups across continents to gather support for community dermatology to manage common and neglected diseases [6] involving skin. He hypothesized the combined use of locally available ancient systems such as ayurveda and yoga. [7] This led to the development a self-care integrative treatment for lymphatic filariasis, a disease affecting over 20 million poor in India. [8],[9] In India, there is a decade of spending on CAM research by scientists, modern doctors; Golden triangle partnership (with science, ayurveda, and allopathy) schemes of government [4] and presence of multispecialty doctors and advanced centers for reverse pharmacology." [10] (See 'Evidence Based Integrative Dermatology' in this issue page no. 127-131) But there are not many IM protocols in India. What prevented expansion of IM to new diseases? The focus of researchers and funding agencies has been on laboratory studies of CAM. There has been little attempt toward collaboration with clinicians of various systems of medicine. There is a lacuna in qualitative and quality studies to validate ayurveda in spite of opportunities offered by the Indian Government. [4] Valiathan blamed it on the teaching and learning culture in medical colleges. [11] Twentieth century Indian doctors adopted ayurveda and allopathy by the transfer of knowledge not understanding the philosophy and method of experimentation behind their development.
The major knowledge base of allopathy and CAM is derived from the same human observation of natural events. Significant differences arose from the interpretations placed on the observations. [12] A modern botanist argues that plants should be classified by their genetic relationship. The ayurvedist classified medical plants on the basis of utility. Combining traditional ayurveda with modern medicine, investigators at IAD worked together to discover where the two knowledge systems complimented each other. IM has the advantage of awareness of at least some of the medium-and long-term side effects. Ayurveda literature has already recorded these long-term events and cycles albeit in a different language culture. [13] Therefore, it is pragmatic to have the scientifically trained and practicing modern doctor, pharmaceutical scientist, and CAM doctors working together. The key to the success is in following each other's method and information, while reviewing their conclusion before prescribing IM. Mutual orientation in patient care of a given disease in allopathy and ayurveda by a multisystem doctors team is probably the first step toward developing an IM treatment protocol. [4] This will lead to the construction of a vikruthi table [4] of comparable biomedical terminology such as the IAD team's vikruthi table for lichen planus. The words are not synonymous in medical systems, but they can be compared by examining the patients together (See "Evidence Based Integrative Dermatology" in this issue page no. 127-131). This collaboration requires understanding epistemology of concerned systems and the influence of culture on the language used to describe. [14]
IAD's experiences exposed new challenges in integrative dermatology. Several procedures used in IM and CAM such as oil massage (udwarthana[9] or IMLD-2) are meant to achieve absorption of oil. Fifty to seventy milliliters of herbal oil are absorbed per IM treatment procedure in lymphedema patients. Vehicles used in topical preparations of CAM are water, ghee, etc., [15],[16],[17] They are proved not effective by pharmaceutical research. Manufacturing and dispensing methods of CAM might lead to loss of its active ingredients. [18] Currently available information and ICT tools are not sufficient to assess the possible interactions of CAM with modern drugs. It would be wise to split the botanicals of each compound preparation of CAM and later to do a systematic search [19] to get leads on active ingredients and drug interactions. However, the active ingredient of the whole compound in vivo may not be the same as in vitro molecules identified in this manner. Furthermore, animal experimentation for toxicity and efficacy trials need to define three doshas, namely vatha, pitta, and kapha, in the experimental animal used. [20] In the pre-patent era, the Indian pharmaceutical industry developed "process technology" to manufacture almost every drug invented in Europe and America. This helped to reduce the cost of modern drugs on the Indian market and retained the same efficacy. Ayurveda drug manufactures should collaborate with clinicians, academia, and modern pharmaceuticals industry to develop processes to improve manufacturing and dispensing of CAM drugs. This should aim at enhancing the clinical potential of traditional drugs. Such drugs with enhanced efficacy would reduce the time required to respond to the treatment and save the herbal raw materials. The demand for CAM usage has increased worldwide. The herbal sources are depleted especially by deforestation or use of roots when leaves will do. Furthermore, they are often replaced by counterfeit preparations. India has no preparedness for post-patent era. Our new drug development capability is not sufficient to provide affordable treatment for a majority of poor. IM will come to the rescue of our patients if hostility among practitioners of Allopathy and CAM is addressed with objectivity. Clinicians, academia, and industry should develop collaboration culture to enhance the clinical potential of IM protocols for common diseases. IM should have the evidence of using proven outcome measures of biomedicine. It should selectively incorporate elements of ayurveda and other CAM based on diagnosis of allopathy. Such collaborations should begin a new era of marketing thousands of drugs in untapped CAM pharmacopeias [21] with their enhanced clinical potential and clearly defined indications for their use.
 References | |  |
| 1. | Godlee F. Integrated care is what we want. Editors choice. Br Med J 2012;344:e3959. 
|
| 2. | Colquhoun D. Science degrees without the science. Nature 2007;446:373-4.
[PUBMED] |
| 3. | Antia NH. Alternative approaches to delivery of medical technology for rural health. Curr Sci 2004;87:967-70.
|
| 4. | Narahari SR, Ryan TJ, Bose KS, Prasanna KS, Aggithaya GM. Integrating modern dermatology and Ayurveda in the treatment of vitiligo and lymphedema in India. Int J Dermatol 2011;50:310-34.
[PUBMED] |
| 5. | Chi-keong ON, Ryan TJ. Healthy Skin for All. 1 st ed. Oxford: International Foundation of Dermatology; 1998.
|
| 6. | Ryan TJ. The International society of Dermatology's Task Force for skin care for all: Community dermatology. Int J Dermatol 2011;50:548-51.
[PUBMED] |
| 7. | Vaqas B, Ryan TJ. Lymphoedema: Pathophysiology and management in resource-poor settings-relevance for lymphatic filariasis control programmes. Filaria J 2003;2:4.
[PUBMED] |
| 8. | World Health Organization: Lymphatic filariasis-Fact sheet [Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/. [Last Accessed on 2012 Aug 8].
|
| 9. | Narahari SR, Ryan TJ, Mahadevan PE, Bose KS, Prasanna KS. Integrated management of filarial lymphedema for rural communities. Lymphology 2007;40:3-13.
[PUBMED] |
| 10. | Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov Today 2009;14:804-11.
[PUBMED] |
| 11. | Valiathan MS. Whither India's medical legacy?. Curr Sci 1990;59:125-7.
|
| 12. | Emrey AR. Integrating indigenous knowledge in project planning and implementation. Washington: World Bank, Canada: Canadian International Development Agency; 2000. Available from: http://www.acdi-cida.gc.ca/inet/images.nsf/vLUImages/ea/$file/IndiKnow-NP-e.pdf. [Last Accessed on 2012 Aug 8].
|
| 13. | Caraka, Rasa vimana. In: Caraka, Dridhabala, Caraka Samhita, editors. Varanasi: Chowkambha Sanskrit Series Office; 2002. verses 15-8.
|
| 14. | Wujastyk D. The Roots of Ayurveda: Selections from Sanskrit Medical Writings. New Delhi: Penguin Classics; 2003.
|
| 15. | Vangasena. Cikitsa Sara Sangraha-Kustadhikara. Varanasi, India: Chowkhamba Sanskrit Series Office; 2004. verse. 286.
|
| 16. | Sarngadhara. Sarngadhara Samhita. Madhyamakhanda Sneha Kalpana. Varanasi: Krishnadas Academy; 2000. verses. 48-50.
|
| 17. | Sarngadhara. Sarngadhara Samhita. Madhyamakhanda Sneha Kalpana. Varanasi: Krishnadas Academy; 2000. verses. 168-91.
|
| 18. | Sarngadhara. Sarngadhara Samhita. Madhyamakhanda Swarasa Kalpana. Varanasi: Krishnadas Academy; 2000. verses. 1-5.
|
| 19. | Narahari SR, Aggithaya MG, Suraj KR. Conducting literature searches on Ayurveda in PubMed, Indian, and other databases. J Altern Complement Med 2010;16:1225-37.
[PUBMED] |
| 20. | Polisetty R, Vladislavovich NP. Effect of various diets prescribed in The Indian System of Medicine on the resting potential of cells. Russ J Physiol-Heart Circ Physiol 2001;280:H2053-60.
|
| 21. | Hunter DJ. WHO's ambitious new European health strategy. BMJ 2012;345:e5928.
[PUBMED] |
|
|
| This article has been cited by | | 1 |
Bridging Ayurveda with evidence-based scientific approaches in medicine |
|
| Bhushan Patwardhan | | EPMA Journal. 2014; 5(1): 19 | | [Pubmed] | [DOI] | | | 2 |
result 2 Document Amalgamation of ayurveda with allopathy: A synergistic approach for healthy society |
|
| Authors of Document Nandha, R., Singh, H. | | International Journal of Green Pharmacy. 2013; | | [Pubmed] | | | 3 |
Community level morbidity control of lymphoedema using self care and integrative treatment in two lymphatic filariasis endemic districts of South India: a non randomized interventional study |
|
| S. R. Narahari,K. S. Bose,M. G. Aggithaya,G. K. Swamy,T. J. Ryan,B. Unnikrishnan,R. G. Washington,B. P. S. Rao,S. Rajagopala,K. Manjula,U. Vandana,T. A. Sreemol,M. Rojith,S. Y. Salimani,M. Shefuvan | | Transactions of the Royal Society of Tropical Medicine and Hygiene. 2013; 107(9): 566 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 3706 | | | Printed | 127 | | | Emailed | 1 | | | PDF Downloaded | 69 | | | Comments | [Add] | | | Cited by others | 3 | | |
|
|
